tetano
Editor, Senior Moderator
J Med Virol
. 2021 Jan 6.
doi: 10.1002/jmv.26777. Online ahead of print.
Clinical characteristic and epidemiological features of SARS CoV -2 disease patients from a COVID 19 designated Hospital in New Delhi
Sonal Saxena[SUP] 1 [/SUP], Vikas Manchanda[SUP] 1 [/SUP], Tanu Sagar[SUP] 1 [/SUP], Nazia Nagi[SUP] 1 [/SUP], Oves Siddiqui[SUP] 1 [/SUP], Abhishek Yadav[SUP] 1 [/SUP], Nitin Arora[SUP] 1 [/SUP], Faria Hasan[SUP] 1 [/SUP], Kavita Meena[SUP] 1 [/SUP], Pradeep Bharti[SUP] 1 [/SUP], Neha Rana[SUP] 1 [/SUP], Sikander Hayat[SUP] 1 [/SUP], Sanchita Tuteja[SUP] 1 [/SUP], Ajeet Yadav[SUP] 1 [/SUP], Devyani Puri[SUP] 1 [/SUP], Palak Pumma[SUP] 1 [/SUP], Khyati[SUP] 1 [/SUP], Ananya Arora[SUP] 1 [/SUP], Jainandra[SUP] 1 [/SUP], Sunidhi Shreya[SUP] 1 [/SUP], Suresh Kumar[SUP] 2 [/SUP], Nandini Sharma[SUP] 3 [/SUP]
Affiliations
Abstract
SARS CoV -2 infection is rapidly evolving as a serious global pandemic. The present study describes the clinical characteristics of SARS CoV-2 infection patients. The Samples were subjected to RT - PCR or Rapid Antigen test for diagnosis of SARS CoV- 2. A cohort of 3745 patients with confirmed diagnosis of SARS CoV -2 infection in a tertiary care center in New Delhi, India were included in this study. Data was collected from offline and online medical records over a period of six months. Amongst 3745 SARS CoV -2 infected patients, 2245 (60%) were symptomatic and 1500 (40%) were asymptomatic. Most common presenting symptom was cough (49.3%) followed febrile episodes (47.1%), breathlessness (42.7%) and sore throat (35.1%). Cough along with breathlessness (24.1) was the most common combination of symptoms followed by fever with cough (22.7). The most common comorbidity found among symptomatic group was diabetes (42.5%) followed by hypertension (21.4%) and chronic kidney disease (18%). Comorbidities like diabetes mellitus, chronic diseases of lungs, heart and kidneys were found to be common in symptomatic group and this was found to be statistically significant (p<0.05). COVID-19 is an evolving disease and data from our study help in understanding the clinic-epidemiological profile of patients. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; SARS-CoV-2; coronavirus disease.
. 2021 Jan 6.
doi: 10.1002/jmv.26777. Online ahead of print.
Clinical characteristic and epidemiological features of SARS CoV -2 disease patients from a COVID 19 designated Hospital in New Delhi
Sonal Saxena[SUP] 1 [/SUP], Vikas Manchanda[SUP] 1 [/SUP], Tanu Sagar[SUP] 1 [/SUP], Nazia Nagi[SUP] 1 [/SUP], Oves Siddiqui[SUP] 1 [/SUP], Abhishek Yadav[SUP] 1 [/SUP], Nitin Arora[SUP] 1 [/SUP], Faria Hasan[SUP] 1 [/SUP], Kavita Meena[SUP] 1 [/SUP], Pradeep Bharti[SUP] 1 [/SUP], Neha Rana[SUP] 1 [/SUP], Sikander Hayat[SUP] 1 [/SUP], Sanchita Tuteja[SUP] 1 [/SUP], Ajeet Yadav[SUP] 1 [/SUP], Devyani Puri[SUP] 1 [/SUP], Palak Pumma[SUP] 1 [/SUP], Khyati[SUP] 1 [/SUP], Ananya Arora[SUP] 1 [/SUP], Jainandra[SUP] 1 [/SUP], Sunidhi Shreya[SUP] 1 [/SUP], Suresh Kumar[SUP] 2 [/SUP], Nandini Sharma[SUP] 3 [/SUP]
Affiliations
- PMID: 33410174
- DOI: 10.1002/jmv.26777
Abstract
SARS CoV -2 infection is rapidly evolving as a serious global pandemic. The present study describes the clinical characteristics of SARS CoV-2 infection patients. The Samples were subjected to RT - PCR or Rapid Antigen test for diagnosis of SARS CoV- 2. A cohort of 3745 patients with confirmed diagnosis of SARS CoV -2 infection in a tertiary care center in New Delhi, India were included in this study. Data was collected from offline and online medical records over a period of six months. Amongst 3745 SARS CoV -2 infected patients, 2245 (60%) were symptomatic and 1500 (40%) were asymptomatic. Most common presenting symptom was cough (49.3%) followed febrile episodes (47.1%), breathlessness (42.7%) and sore throat (35.1%). Cough along with breathlessness (24.1) was the most common combination of symptoms followed by fever with cough (22.7). The most common comorbidity found among symptomatic group was diabetes (42.5%) followed by hypertension (21.4%) and chronic kidney disease (18%). Comorbidities like diabetes mellitus, chronic diseases of lungs, heart and kidneys were found to be common in symptomatic group and this was found to be statistically significant (p<0.05). COVID-19 is an evolving disease and data from our study help in understanding the clinic-epidemiological profile of patients. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; SARS-CoV-2; coronavirus disease.